OakChart

Charles River Laboratories International Inc

CRLHealthcare·Diagnostics & Research·USA·Large·NYSE·Nov 11 • 10:09 AM ET

348.80+3.00 (0.87%)
2026-11-11 16:09 CET
Market cap
16,569.87 USD m
Revenue, TTM
3,976.87 USD m
Net income, TTM
40.19 USD m
Free cash flow, TTM
399.63 USD m
EPS diluted, TTM
0.90
P/E
386.60
Compare

Price

CRL against its 20, 50 and 200-day averages
2050200beatmiss
200.00300.001.4M2.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CRLclose 348.8020-day 339.6350-day 309.31200-day 226.49348.80

8.1% under 379.63 on 29 Oct 2026. Last 15 sessions, 21.8% high to low

Profile

CRL
52-week range, 87% of the way up
146.2379.63

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

IndexS&P 500, RUI
Employees19700
IPOJun 23, 2000
Beta1.34
ATR, 14d16.77
Rel volume0.39
Short float6.30%
Insider own1.12%
Inst own118.90%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap16.71B
Enterprise Value19.39B
Income40.19M
Sales3.98B
Book/sh67.40
Cash/sh4.75
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees19700
IPOJun 23, 2000

Ratios

P/E386.60
Forward P/E26.99
PEG2.24
P/S4.20
P/B5.17
P/C73.46
P/FCF41.82
EV/EBITDA21.63
EV/Sales4.87
Quick Ratio1.12
Current Ratio1.41
Debt/Eq0.88
LT Debt/Eq0.88
Option/ShortYes / Yes

Earnings

EPS (ttm)0.90
EPS next Y12.92
EPS next Q3.32
EPS this Y11.55%
EPS next Y12.69%
EPS next 5Y12.07%
EPS past 3/5Y- -
Sales past 3/5Y0.33% 6.55%
EPS Y/Y TTM165.65%
Sales Y/Y TTM-1.16%
EPS Q/Q522.60%
Sales Q/Q-2.20%
EarningsNov 04 BMO
EPS/Sales Surpr.3.94% 2.33%

Ownership

Insider Own1.12%
Insider Trans-26.47%
Inst Own118.90%
Inst Trans-1.93%
ROA0.54%
ROE1.21%
ROIC0.66%
Gross Margin33.45%
Oper. Margin15.37%
Profit Margin1.01%
SMA202.70%
SMA5012.76%
SMA20054.00%
Trades-

Technical

Shs Outstand47.88M
Shs Float47.38M
Short Float6.30%
Short Ratio2.81
Short Interest2.99M
52W High379.63 -8.12%
52W Low146.20 138.58%
Volatility6.09% 5.18%
ATR (14)16.77
RSI (14)56.35
Beta1.34
Rel Volume0.39
Avg Volume1.06M
Volume59,811

Performance

Perf Week6.90%
Perf Month16.65%
Perf Quarter24.01%
Perf Half Y114.18%
Perf YTD74.85%
Perf Year101.03%
Perf 3Y102.80%
Perf 5Y-10.58%
Perf 10Y367.37%
Recom1.85
Target Price363.57
Prev Close345.80
Price348.80
Change %0.87%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 30, 2026ResumedUUBSBuy$357+2.4%
Aug 06, 2026UpgradeJJP MorganNeutral → Overweight$310-11.1%
Jul 20, 2026DowngradeCCLSAOutperform → Hold$219-37.2%
Jun 17, 2026UpgradeMMorgan StanleyEqual-Weight → Overweight$220-36.9%
May 29, 2026UpgradeCCLSAHold → Outperform$219-37.2%
Apr 14, 2026InitiatedRRBC Capital MktsOutperform$215-38.4%
Dec 15, 2025UpgradeBBofA SecuritiesNeutral → Buy$225-35.5%
Nov 17, 2025UpgradeAArgusHold → Buy
Nov 06, 2025UpgradeRRobert W. BairdNeutral → Outperform$199-42.9%
Oct 06, 2025UpgradeWWilliam BlairMkt Perform → Outperform

Peers

Mkt cap
TickerCompanyMkt cap
LHLabcorp Holdings Inc30.09B
TMOThermo Fisher Scientific Inc267.23B
ICLRIcon Plc15.20B
MEDPMedpace Holdings Inc18.56B
IQVIQVIA Holdings Inc45.86B
SHCSotera Health Co4.69B
FTREFortrea Holdings Inc2.04B
AZTAAzenta Inc2.07B
SDGRSchrodinger Inc2.45B
CERTCertara Inc1.84B

Insider trading

latest 14 of 39
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
FOSTER JAMES CDirectorOct 22 '26Option Exercise244.4124,0425,876,10555,638Oct 26 04:51 PM
FOSTER JAMES CDirectorOct 22 '26Sale350.0024,0428,414,70031,596Oct 26 04:51 PM
Parisotto Shannon MCEVP, Disc & Safety AssessmentOct 21 '26Option Exercise244.412,156526,9486,963Oct 23 06:45 PM
Parisotto Shannon MCEVP, Disc & Safety AssessmentOct 21 '26Sale344.412,156742,5484,807Oct 23 06:45 PM
FOSTER JAMES CDirectorOct 22 '26Proposed Sale350.0024,0428,414,700Oct 22 04:03 PM
Parisotto Shannon MOfficerOct 21 '26Proposed Sale344.412,156742,548Oct 21 04:05 PM
Parisotto Shannon MCEVP, Disc & Safety AssessmentOct 05 '26Option Exercise208.44981204,4805,788Oct 07 08:32 PM
Parisotto Shannon MCEVP, Disc & Safety AssessmentOct 05 '26Sale308.44981302,5804,807Oct 07 08:32 PM
Parisotto Shannon MOfficerOct 05 '26Proposed Sale314.56981308,580Oct 05 04:25 PM
Coleman GlennEVP & Chief Financial OfficerSep 30 '26Buy297.43102,97427,762Oct 02 04:27 PM
FOSTER JAMES CDirectorAug 25 '26Option Exercise199.4233,5616,692,84565,157Aug 27 04:21 PM
FOSTER JAMES CDirectorAug 25 '26Sale300.0033,56110,068,30031,596Aug 27 04:21 PM
FOSTER JAMES CDirectorAug 25 '26Proposed Sale299.9333,56110,065,951Aug 25 04:10 PM
Parisotto Shannon MCEVP, Disc & Safety AssessmentAug 19 '26Option Exercise194.122,039395,8116,846Aug 20 04:33 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B
IVViShares Core S&P 500 ETFAUM: 871.38B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
IBBiShares Biotechnology ETFAUM: 11.36B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
IWRiShares Russell Mid-Cap ETFAUM: 58.68B

News

latest 14 of 206
  • Charles River agrees $470m deal for Frontage assets (Hospital Management)
  • Charles River Laboratories to Acquire Frontages Bioanalysis and DMPK Businesses (Business Wire)
  • Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch) +7.83%
  • Charles River Turns Bookings Into Revenue: Organic Growth Hits A Three-Year High, But A Rerated Stock Now Has To Bridge A 'Gradual' 2027 (Earnings Whispers) -7.27%
  • Charles River Labs, A Top 2% Medical Stock, Drops Despite Its Beat And Raise (Investor's Business Daily)
  • Loading…
  • Charles River: Q3 Earnings Snapshot (Associated Press)
  • Charles River Laboratories Announces Third-Quarter 2026 Results (Business Wire)
  • In a wild October for markets, these stocks were the biggest winners and losers (MarketWatch)
  • Charles River's 34% Rally Puts Its DSA Bookings Recovery Under A Brighter Spotlight (Earnings Whispers)
  • Charles River Leverages Virtual Control Groups in GLP Studies (Business Wire)
  • Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment (Business Wire)
  • Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch) +5.14% +9.33%
  • The Healthcare Sector Nears a New High. These Stocks Are Leading the Charge. (Barrons.com)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-043.0902.9736.860982.73960.3614
2026Q22026-08-053.0202.742-0.0311,004977.213
2026Q12026-05-072.0601.944-0.303995.83977.4614
2025Q42026-02-182.3902.346-5.619994.23987.0214
2025Q32025-11-052.4302.3381.1011,005990.8214
2025Q22025-08-063.1202.5021.0611,032985.2414
2025Q12025-05-072.3402.0760.501984.17941.9714
2024Q42025-02-192.6602.528-4.2181,003983.6316
2024Q32024-11-062.5902.4231.3311,010975.9916
2024Q22024-08-072.8002.3941.7361,0261,02416
2024Q12024-05-092.2702.0651.4071,012992.3114
2023Q42024-02-142.4602.4023.6241,013991.2514
2023Q32023-11-082.7202.3571.6931,0271,00014
2023Q22023-08-092.6902.6381.8851,0601,05414
2023Q12023-05-112.7802.5882.0051,029986.3114
2022Q42023-02-222.9802.7453.6481,1001,03514

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY6.7306.5545.0722,6212,614
2020FY8.1307.8587.1982,9242,890
2021FY10.32010.2657.6033,5403,522
2022FY11.12010.8909.4783,9763,912
2023FY10.67010.5929.2254,1294,107
2024FY10.32010.1830.1994,0504,030
2025FY10.28010.242-2.9104,0154,005
2026FY-11.468--3,945
2027FY-12.923--4,049
2028FY-14.471--4,288
2029FY-16.679--4,547
2030FY-17.705--4,787

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-061290968.84950.811,014
2026Q4S2026-11-051290968.84950.811,014
2026Q4S2026-11-041290968.81950.811,014
2026Q4S2026-10-211200956.34945974.1
2026Q4S2026-10-201210956.34945974.1
2026Q4S2026-10-191220956.34945974.1
2026Q4S2026-10-151270956.34945974.1
2026Q4S2026-10-131260955.64945974.1
2026Q4S2026-10-021260955.12943974.1
2026Q4S2026-09-281260954.61943974.1
2026Q4S2026-09-251150953.4943974.1
2026Q4S2026-09-241150952.23943974.1
2026Q4S2026-09-231150952.22943974
2026Q4S2026-09-181150952.25943974

Estimate history

EPS, annual2.544.6185.0727.1987.6039.4789.2250.199-2.9120.9022
Period201720182019202020212022202320242025TTM
EPS, quarterly1.331-4.2180.5011.0611.101-5.619-0.303-0.0316.856
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1857.6012266.0962621.2262923.9333540.163976.064129.4094049.9894015.3823976.87
Period201720182019202020212022202320242025TTM
Sales, quarterly1009.7631002.549984.1681032.1351004.852994.227995.831004.078982.732
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual47.40248.20948.93649.76750.4850.94451.33851.14149.21747.876
Period201720182019202020212022202320242025MRQ
Shares, quarterly51.13451.14149.11549.20949.21549.21748.16747.72847.876
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue3,976.874,015.384,049.994,129.413,976.063,540.162,923.932,621.232,266.10
Cost of Goods Sold Incl. D&A2,646.642,789.812,780.512,737.662,659.992,330.511,959.911,749.911,495.05
Gross Profit1,330.231,225.571,269.471,391.741,316.071,209.64964.02871.31771.05
Selling, General and Administrative Excl. Other719.04709.73702.60730.61663.49607.21505.06478.72412.92
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income611.19515.84566.88661.13652.59602.43458.95392.59358.13
Interest Expense109.38107.03126.29136.71109.00108.0477.1179.5563.77
Unusual Expense477.11515.58352.4343.8725.2010.44-54.162.1819.75
Net Income Before Taxes-100.21-99.5093.11581.28622.99480.71447.11304.08281.68
Income Taxes-142.8142.6667.82100.91130.3881.8781.8150.0254.46
Consolidated Net Income42.59-142.1625.29480.37492.61398.84365.31254.06227.22
Net Income From Continuing Operations40.19-144.3410.30474.62486.23390.98364.30252.02224.87
Net Income40.19-144.3410.30474.62486.23390.98364.30252.02226.37
EPS (Recurring)7.704.374.989.829.827.756.455.104.90
EPS (Basic, Before Extraordinaries)1.01-2.910.209.279.577.777.355.174.72
EPS (Diluted)0.90-2.910.209.229.487.607.205.074.62
EBITDA896.17919.15928.62975.26956.46867.97693.88590.68519.91
Non-Operating Income (Expense)-124.917.264.96100.73104.61-3.2411.11-6.777.07
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense54.8960.0059.4061.1462.6561.1748.2147.8138.16
Price To Earnings Ratio383.29383.2922.7925.6125.6549.5634.7330.1224.55
Price To Sales Ratio3.582.512.372.952.815.364.362.882.42
Gross Margin33.4530.5231.3533.7033.1034.1732.9733.2434.03
Operating Margin15.3712.8514.0016.0116.4117.0215.7014.9815.80
Net Margin1.01-3.590.2511.4912.2311.0412.469.619.99
Shares Outstanding47.8849.2251.1451.3450.9450.4849.7748.9448.21
Market Capitalization16,569.8716,569.879,439.7412,126.5611,086.4719,013.9812,428.697,460.655,443.51

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue982.731,004.08995.83994.231,004.851,032.13984.171,002.55
Cost of Goods Sold Incl. D&A632.47639.65688.14686.37680.12713.98709.33724.09
Gross Profit350.26364.42307.69307.86324.73318.16274.83278.46
Selling, General and Administrative Excl. Other128.41214.18187.62188.84173.65185.82176.32180.04
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income221.85150.25120.08119.02151.08132.3398.5198.42
Interest Expense28.5230.3426.7423.7725.4029.9727.8828.23
Unusual Expense21.6522.2839.82393.3617.2832.2023.84287.40
Net Income Before Taxes170.6653.17-29.94-294.1087.2071.4235.98-216.79
Income Taxes-163.7953.93-15.14-17.8131.6418.7310.10-3.04
Consolidated Net Income334.44-0.76-14.80-276.2955.5652.6925.88-213.75
Net Income From Continuing Operations333.07-1.48-14.84-276.5654.4252.3325.47-215.70
Net Income333.07-1.48-14.84-276.5654.4252.3325.47-215.70
EPS (Recurring)7.170.290.27-0.021.351.520.83-0.28
EPS (Basic, Before Extraordinaries)6.97-0.03-0.30-5.621.111.060.50-4.22
EPS (Diluted)6.86-0.03-0.30-5.621.101.060.50-4.22
EBITDA294.11217.53187.23197.30236.25251.84218.88200.52
Non-Operating Income (Expense)-1.01-44.45-83.464.02-21.201.25-10.810.43
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense16.4115.6317.685.1742.2313.4710.3813.62
Price To Earnings Ratio383.29-----586.8222.79
Price To Sales Ratio3.582.591.932.501.821.841.972.35
Gross Margin35.6436.2930.9030.9632.3230.8327.9327.77
Operating Margin22.5714.9612.0611.9715.0412.8210.019.82
Net Margin33.89-0.15-1.49-27.825.425.072.59-21.52
Shares Outstanding47.8847.7348.1749.2249.2249.2149.1251.14
Market Capitalization16,569.8710,923.958,491.809,817.517,700.057,452.337,697.839,439.74

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments214.44204.14282.57241.10246.30232.52239.39196.79192.88
Short Term Receivables708.86720.91780.38752.39650.38617.74514.03472.25430.02
Inventories299.10278.54380.26255.81199.15185.69160.66127.89114.96
Other Current Assets224.65199.47165.45189.73178.27165.17107.25100.9088.78
Total Current Assets1,447.051,403.071,608.661,439.031,274.101,201.131,021.33897.84826.62
Net Property, Plant & Equipment2,016.632,016.502,033.771,857.421,584.011,302.581,184.21932.88781.97
Total Investments and Advances208.53219.78245.72312.71202.43223.43124.5890.0073.05
Intangible Assets3,104.253,570.013,959.103,805.183,773.072,596.772,229.981,858.021,174.67
Deferred Tax Assets67.3342.1840.2841.2640.2337.7344.6623.3922.65
Other Assets291.62276.81307.48147.17150.46129.2088.0353.7650.96
Total Assets7,135.427,528.358,195.007,602.777,024.295,490.834,692.793,855.882,929.92
Short Term Debt Incl. Current Port. of LT Debt61.0657.0960.4850.2036.0674.8958.9031.4231.00
Accounts Payable148.80140.34168.94205.91198.13122.47111.5066.2577.84
Income Tax Payable39.0031.9038.8039.9026.1624.8826.0724.1243.25
Other Current Liabilities871.46764.78786.87795.57772.83617.50513.72436.44311.42
Total Current Liabilities1,120.32994.101,055.081,091.591,033.18839.75710.18558.22463.50
Long Term Debt2,570.412,723.993,066.383,097.282,916.542,085.171,965.921,636.601,114.11
Provision for Risks Charges0.000.000.0044.10148.00123.0195.1276.73113.40
Deferred Tax Liabilities95.20106.96191.35215.58239.72217.03167.28143.6389.54
Other Liabilities138.30195.21223.19130.7294.8682.2087.81102.3985.36
Total Liabilities3,924.234,020.274,536.004,579.274,432.303,347.163,026.322,517.581,865.91
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity3,164.633,461.503,596.882,976.292,534.822,114.601,634.581,317.331,045.08
Total Shareholders Equity3,164.633,461.503,596.882,976.292,534.822,114.601,634.581,317.331,045.08
Accumulated Minority Interest46.5646.5862.1247.2157.1729.0731.8920.9718.94
Total Equity3,211.193,508.083,659.003,023.512,591.992,143.671,666.471,338.301,064.02
Total Liabilities & Stockholders Equity7,135.427,528.358,195.007,602.777,024.295,490.834,692.793,855.882,929.92
Book Value Per Share64.3067.6970.0658.4250.2142.4933.4027.3322.05
Tangible Book Value Per Share1.23-2.12-7.06-16.27-24.53-9.69-12.17-11.22-2.73
Full-Time Employees19,70020,10021,80021,40020,00018,40017,10014,70011,800
Price to Book Ratio5.132.503.674.227.505.884.574.145.07
Return on Assets-1.970.136.016.656.257.155.906.634.38
Return on Equity-4.360.2914.4417.6516.8219.4317.0719.0413.12
Return on Invested Capital-2.520.177.128.017.178.677.007.665.71
Quick Ratio1.021.131.161.081.041.211.211.381.54
Current Ratio1.291.411.521.321.231.431.441.611.78

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income42.59-142.1625.29480.37492.61398.84365.31258.14227.22
Depreciation284.98403.31361.74314.12303.87265.54234.92198.09161.78
Other Funds (Non Cash)378.45537.71445.3042.6911.6077.49-27.2544.5047.03
Funds from Operations641.76723.57764.91786.28772.19717.86572.85474.76426.33
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-19.3514.08-30.33-102.38-152.5542.94-26.276.1814.81
Cash from Operating Activities622.41737.65734.58683.90619.64760.80546.58480.94441.14
Capital Expenditures-222.77-219.15-232.97-318.53-324.73-228.77-166.56-140.51-140.05
Net Assets From Acquisitions-448.110.00-5.48-194.78-283.39-1,293.10-418.63-515.70-824.87
Sale of Fixed Assets and Businesses176.5617.440.000.00163.28122.690.000.000.00
Purchase or Sale of Investments0.09-10.97-11.19-47.55-153.72-39.02-15.29-21.4010.72
Purchase of Investments-22.25-20.08-52.88-54.22-158.27-45.55-26.69-22.34-25.12
Sale Or Maturity of Investments22.349.1041.696.674.556.5311.400.9435.85
Other Uses-7.290.000.00-2.29-9.350.00-1.06-3.89-4.54
Other Sources58.343.364.550.000.000.260.000.000.00
Cash from Investing Activities-443.19-209.32-245.09-563.15-607.92-1,437.93-601.54-681.50-958.74
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-293.76-359.96-95.301.44-13.544.9522.6116.4623.81
Repurchase of Common Pref Stock-324.20-360.67-119.17-24.16-38.65-40.71-23.98-18.09-13.85
Sale of Common Pref Stock30.440.7123.8825.6025.1145.6546.5934.5537.66
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net287.81-121.78-412.19-75.3219.79669.9830.59227.28535.69
Change in Long Term Debt287.81-121.78-412.19-75.3219.79669.9830.59227.28535.69
Issuance of Long Term Debt1,576.901,227.531,081.58776.352,952.436,912.862,230.993,351.872,736.69
Reduction of Long Term Debt-1,289.08-1,349.32-1,493.77-851.68-2,932.64-6,242.88-2,200.40-3,124.59-2,201.00
Net Financing Active Other Cash Flow-117.00-54.98-43.44-11.64-48.65-2.33-5.95-11.80-1.44
Other Financing Activities Uses-117.00-54.98-43.44-11.64-48.65-2.33-5.95-11.80-1.44
Cash from Financing Activities-122.95-536.73-550.93-85.52-42.40672.6047.25231.94558.06
Exchange Rate Effect2.7318.83-17.478.0425.5817.730.7911.36-9.47
Net Change in Cash39.8610.43-78.9143.27-5.1013.20-6.9342.7330.99
Free Cash Flow399.63518.49501.61365.37294.91532.03380.01340.42301.09
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow35.6019.4719.1633.2937.9135.6933.5222.1818.19
Deferred Taxes & Investment Tax Credit--75.29-67.43-50.90-35.88-24.01-0.13-21.89-9.70

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments227.53216.45193.76214.44207.67183.22
Short Term Receivables735.30711.75700.25708.86734.48767.57
Inventories319.64346.26359.72299.10302.55279.55
Other Current Assets252.56254.64235.07224.65287.40239.52
Total Current Assets1,535.031,529.111,488.811,447.051,532.101,469.86
Net Property, Plant & Equipment2,210.622,216.772,234.252,016.631,965.901,992.49
Total Investments and Advances216.07230.60211.32208.53196.19217.59
Intangible Assets3,322.773,330.033,289.023,104.253,493.383,538.72
Deferred Tax Assets67.4753.8388.6067.3336.9146.94
Other Assets99.54171.82418.31291.62289.34294.94
Total Assets7,451.517,532.157,730.317,135.427,513.817,560.55
Short Term Debt Incl. Current Port. of LT Debt3.126.638.2961.062.642.93
Accounts Payable144.51140.98133.95148.80169.62145.80
Income Tax Payable41.3645.0348.7439.0055.3740.91
Other Current Liabilities900.28942.11902.73871.46894.27890.80
Total Current Liabilities1,089.261,134.751,093.701,120.321,121.891,080.44
Long Term Debt2,848.813,027.693,056.252,570.412,628.642,786.04
Provision for Risks Charges83.70283.08267.870.000.000.00
Deferred Tax Liabilities81.8178.6781.4095.20123.01109.27
Other Liabilities72.66119.43242.78138.30189.46185.21
Total Liabilities4,176.244,643.624,741.993,924.234,062.994,160.96
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity3,227.012,839.642,940.593,164.633,405.453,353.32
Total Shareholders Equity3,227.012,839.642,940.593,164.633,405.453,353.32
Accumulated Minority Interest48.2648.8947.7246.5645.3746.27
Total Equity3,275.272,888.532,988.313,211.193,450.823,399.59
Total Liabilities & Stockholders Equity7,451.517,532.157,730.317,135.427,513.817,560.55
Book Value Per Share67.4059.5061.0564.3069.2068.14
Tangible Book Value Per Share-2.00-10.27-7.231.23-1.79-3.77
Full-Time Employees---19,700--
Price to Book Ratio5.133.712.682.882.302.33
Return on Assets0.54-3.16-2.41-1.97-1.08-0.89
Return on Equity1.21-7.70-6.02-4.36-2.32-1.96
Return on Invested Capital5.48-0.03-0.25-4.820.900.85
Quick Ratio1.121.041.031.021.101.10
Current Ratio1.411.351.361.291.371.36

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income334.44-0.76-14.80-276.2955.5652.69
Depreciation72.2667.2967.1578.2885.16119.51
Other Funds (Non Cash)-216.5871.88124.22398.9352.3443.23
Funds from Operations173.96179.90147.16140.75218.97193.44
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital80.13-0.18-106.086.77-5.1411.17
Cash from Operating Activities254.09179.7241.08147.52213.83204.60
Capital Expenditures-46.81-31.11-55.91-88.95-35.58-35.30
Net Assets From Acquisitions0.00-62.25-405.0119.140.000.00
Sale of Fixed Assets and Businesses0.00116.4760.100.000.000.00
Purchase or Sale of Investments4.904.82-5.57-4.07-0.92-2.28
Purchase of Investments-2.91-3.31-8.49-7.53-4.45-2.79
Sale Or Maturity of Investments7.828.142.923.463.530.50
Other Uses-5.990.16-1.460.000.000.00
Other Sources58.130.000.000.212.810.24
Cash from Investing Activities10.2328.10-407.85-73.67-33.70-37.34
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock27.89-115.20-207.060.61-0.09-7.35
Repurchase of Common Pref Stock-0.22-115.60-208.28-0.10-0.09-7.35
Sale of Common Pref Stock28.110.401.220.710.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-180.37-37.45556.79-51.14-146.30-191.29
Change in Long Term Debt-180.37-37.45556.79-51.14-146.30-191.29
Issuance of Long Term Debt154.97352.80912.46156.67107.50547.02
Reduction of Long Term Debt-335.34-390.25-355.68-207.82-253.79-738.31
Net Financing Active Other Cash Flow-101.66-12.01-2.00-1.33-6.23-47.42
Other Financing Activities Uses-101.66-12.01-2.00-1.33-6.23-47.42
Cash from Financing Activities-254.15-164.66347.72-51.86-152.62-246.06
Exchange Rate Effect-1.67-0.781.253.93-3.0312.67
Net Change in Cash8.5042.38-17.806.7824.48-46.99
Free Cash Flow207.28148.62-14.8358.57178.25169.31
Price to Free Cash Flow35.6027.9619.9119.3313.5112.79

Revenue breakdown

Product2024: 745.85M 2025: 765.28M
Service2024: 3.30B 2025: 3.25B
Asia Pacific2024: 196.95M 2025: 205.02M
Canada2024: 482.09M 2025: 501.03M
Europe2024: 1.08B 2025: 1.10B
Other2024: 52.82M 2025: 64.87M
United States2024: 2.24B 2025: 2.14B
Discovery and Safety Assessment2024: 2.45B 2025: 2.40B
Manufacturing Support2024: 769.33M 2025: 766.41M
Research Models and Services2024: 829.38M 2025: 846.08M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.30%3.0M47.4M1.02M
2026-10-156.00%2.8M47.2M945.25K
2026-09-306.10%2.9M47.2M922.66K
2026-09-154.73%2.2M47.2M912.68K
2026-08-315.37%2.5M47.2M890.23K
2026-08-145.00%2.4M47.2M921.03K
2026-07-317.25%3.4M47.2M895.74K
2026-07-157.02%3.3M47.6M878.25K
2026-06-309.14%4.4M47.6M886.34K
2026-06-157.60%3.6M47.5M855.81K
2026-05-298.20%3.9M47.5M898.44K
2026-05-157.63%3.6M47.6M970.17K
2026-04-307.02%3.3M47.7M1.02M
2026-04-159.58%4.7M48.7M988.81K
2026-03-319.45%4.6M48.6M984.58K
2026-03-137.73%3.8M48.6M925.04K
2026-02-277.28%3.5M48.6M893.14K
2026-02-136.08%3.0M48.6M816.45K
2026-01-305.53%2.7M48.6M823.89K
2026-01-155.83%2.8M48.6M926.86K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call80.00264.9269.5179.25.2000.000.000.985-0.6230.021
call85.00260264.50.004.8330.000.000.984-0.6240.022
call90.00255.5259.50.004.6410.000.000.983-0.6240.023
call95.00250.1254.5228.64.4611.000.000.983-0.6240.024
call100245.4249.50.004.2910.000.000.982-0.6240.024
call105240.5244.50.004.1290.000.000.981-0.6230.025
call110235.5239.50.003.9180.000.000.980-0.6230.026
call115230.5234.50.003.8300.000.000.979-0.6210.027
call120225229.50.003.6910.000.000.979-0.6200.028
call125220224.5206.43.5581.000.000.978-0.6190.029
call130215.5219.50.003.4300.000.000.977-0.6170.030
call135210.5214.50.003.4540.000.000.976-0.6160.031
call140205209.50.003.1890.000.000.975-0.6140.032
call145200.5204.50.003.0680.000.000.974-0.6120.033
call150195.5199.524.153.1013.000.000.973-0.6100.034
call155190.5194.5122.42.9911.000.000.972-0.6070.035
call160185.6189.552.802.8851.000.000.971-0.6050.036
call165180184.50.002.7820.000.000.970-0.6020.037
call170175.4179.50.002.6820.000.000.969-0.5990.038
call175170.6174.50.002.5850.000.000.968-0.5960.040
call180165.5169.5118.72.4911.000.000.967-0.5930.041
call185160.5164.5141.12.3991.000.000.965-0.5900.042
call190155.4159.5163.62.3101.000.000.964-0.5860.043
call195150.3154.5108.82.2231.000.000.963-0.5830.045
call200145.4149.5131.422.13810.000.000.961-0.5790.046
call210135.5139.5120.181.97461.000.000.958-0.5710.049
call220125.3129.5156.41.8382.000.000.955-0.5620.052
call230115.5119.5108.21.6875.000.000.951-0.5520.056
call240105.5109.519.961.5401.000.000.947-0.5420.059
call25095.60100122.421.34576.000.000.942-0.5300.064
call26085.6090.00112.671.21226.000.000.937-0.5170.068
call27075.8080.0040.061.1294.000.000.930-0.5020.074
call28065.9070.0068.000.9993030.000.922-0.4850.080
call29056.4060.0055.100.8711110.000.912-0.4660.088
call30046.7050.5047.250.7972420.000.899-0.4430.097
call31037.0041.0049.000.74989.000.000.882-0.4160.108
call32028.6032.5029.750.6751330.000.802-0.5940.153
call33020.7024.9019.000.66171.000.000.721-0.6700.185
call34014.3018.0020.960.6481070.000.615-0.7430.210
call3509.5012.7016.300.6328770.000.498-0.7560.219
call3605.809.0011.800.63428.000.000.386-0.7360.210
call3702.856.509.060.6553740.000.301-0.7030.191
call3800.854.704.390.6823510.000.228-0.6330.166
call3900.803.702.500.7341,9340.000.179-0.5860.143
call4000.053.101.800.7846080.000.147-0.5510.127
call4100.052.351.310.81592.000.000.114-0.4780.106
call4200.002.602.650.8991660.000.105-0.4990.100
call4300.002.407.900.97834.000.000.099-0.5170.095
call4400.002.300.221.0391040.000.092-0.5230.091
call4500.002.204.751.1004.000.000.085-0.5200.086
call4600.002.200.121.17025.000.000.081-0.5330.083
call4700.002.150.951.2311.000.000.076-0.5360.079
call4800.002.150.701.2991.000.000.073-0.5470.076
call4900.000.050.200.7761230.000.004-0.0260.006
put80.000.002.150.205.1411.000.00-0.013-0.5260.019
put85.000.002.151.204.9365.000.00-0.014-0.5260.019
put90.000.002.151.354.7439.000.00-0.014-0.5260.020
put95.000.002.151.004.5627.000.00-0.015-0.5250.021
put1000.002.151.304.3916.000.00-0.016-0.5250.022
put1050.002.152.654.2294.000.00-0.016-0.5240.023
put1100.002.152.604.3842.000.00-0.022-0.7010.029
put1150.002.150.004.2270.000.00-0.023-0.7000.030
put1200.002.150.954.0765.000.00-0.024-0.6980.031
put1250.002.155.603.6541.000.00-0.019-0.5180.026
put1300.002.150.003.7950.000.00-0.026-0.6930.033
put1350.002.150.003.6630.000.00-0.027-0.6900.034
put1400.002.150.003.2830.000.00-0.022-0.5120.028
put1450.002.1510.403.1691.000.00-0.022-0.5100.029
put1500.002.150.003.3330.000.00-0.032-0.7100.039
put1550.002.1514.003.21810.000.00-0.033-0.7070.040
put1600.002.150.003.1060.000.00-0.034-0.7030.041
put1650.002.150.002.7490.000.00-0.026-0.5000.033
put1700.002.150.002.6520.000.00-0.027-0.4970.034
put1750.002.150.002.7910.000.00-0.038-0.6910.045
put1800.002.150.002.6920.000.00-0.039-0.6860.047
put1850.002.150.452.3763.000.00-0.030-0.4880.038
put1900.002.150.452.28928.000.00-0.031-0.4850.039
put1950.002.150.832.20511.000.00-0.032-0.4810.040
put2000.002.151.072.1222.000.00-0.034-0.4780.041
put2100.002.150.852.14715.000.00-0.049-0.6550.056
put2200.002.151.181.98263.000.00-0.053-0.6420.059
put2300.002.150.371.74012.000.00-0.048-0.5280.055
put2400.002.150.301.66943.000.00-0.062-0.6140.067
put2500.002.200.201.5201230.00-0.068-0.5980.072
put2600.002.250.501.2801750.00-0.059-0.4550.065
put2700.002.301.121.23575.000.00-0.082-0.5610.083
put2800.002.451.151.3161000.00-0.127-0.8180.114
put2900.002.702.241.1631620.00-0.141-0.7780.123
put3000.052.400.900.7772890.00-0.101-0.4100.097
put3100.202.151.700.6491850.00-0.118-0.3820.108
put3200.854.303.350.67487.000.00-0.198-0.5590.153
put3302.906.204.900.6415660.00-0.273-0.6500.183
put3406.809.507.600.61054.000.00-0.385-0.7050.210
put35011.5014.4014.400.5911220.00-0.502-0.7170.219
put36017.0020.8020.400.60646.000.00-0.614-0.6960.210
put37024.5028.5035.900.67366.000.00-0.701-0.6650.191
put38032.7036.800.000.6840.000.00-0.774-0.5910.165
put39041.8046.2051.930.7711.000.00-0.821-0.5420.143
put40051.1055.40124.30.8321.000.00-0.853-0.5080.126
put41060.9065.4079.500.8870.000.00-0.886-0.4330.106
put42070.6074.900.000.9750.000.00-0.895-0.4520.100
put43080.5084.70143.31.0320.000.00-0.901-0.4690.095
put44090.5094.800.001.1110.000.00-0.908-0.4760.090
put450100.5104.80.001.1880.000.00-0.916-0.4720.085
put460110.6115.21201.2720.000.00-0.920-0.4840.082
put470120.5125.1140.81.3320.000.00-0.924-0.4850.078
put480130.5135.2141.41.4320.000.00-0.927-0.4940.076
put490140.5144.80.001.4670.000.00-0.9960.0270.006

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13G/ASEC
2026-11-094Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-11-05SCHEDULE 13G/ASEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-26SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-22144Filing for proposed sale of securities under Rule 144.SEC
2026-10-21144Filing for proposed sale of securities under Rule 144.SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-05144Filing for proposed sale of securities under Rule 144.SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-248-KCurrent report2026-09-24SEC
2026-09-08SCHEDULE 13G/ASEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-25144Filing for proposed sale of securities under Rule 144.SEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-18SEC
2026-08-19144Filing for proposed sale of securities under Rule 144.SEC
2026-08-18144Filing for proposed sale of securities under Rule 144.SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-13SCHEDULE 13GSEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-10144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-10009.46M3
2026-092.97K100
2026-080025.73M9
2026-070000
2026-060016.88M1
2026-050000
2026-040000
2026-034.36K100
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
FMR LLC12.51%
BlackRock, Inc.7.89%
VANGUARD CAPITAL MANAGEMENT LLC6.54%
Invesco Ltd.6.20%
HARRIS ASSOCIATES L P4.65%
VANGUARD PORTFOLIO MANAGEMENT LLC4.59%
STATE STREET CORP3.87%
ARIEL INVESTMENTS, LLC3.13%
PRICE T ROWE ASSOCIATES INC /MD/3.13%
GEODE CAPITAL MANAGEMENT, LLC2.72%

Funds

Fund% owned
Income Fund of America57.80%
VANGUARD HIGH-YIELD CORPORATE FUND39.39%
High Yield Bond Series14.61%
SMALLCAP World Fund Inc14.06%
Fidelity Advisor Strategic Income Fund12.53%
BrandywineGLOBAL - HIGH YIELD FUND11.62%
Victory Short-Term Bond Fund10.38%
American High Income Trust10.10%
American Funds Multi-Sector Income Fund7.27%
Fidelity Capital and Income Fund7.06%

OakChart. CRL. Cached 15 minutes.